Brind.

Freedom Capital upgraded AngioDynamics to strong-buy, while MarketBeat reported the company's average rating.

1 report, 1 independent Updated Jul 18

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Freedom Capital MarketBeat

Keep exploring

The entities involved

Freedom Capital
company in the Czech Republic
- Rating upgrades and restatements on ASML shares, including an upgrade from hold to strong-buy, were announced.Sun 18:16
- Director Kang Lee sold company shares and Freedom Capital upgraded Photronics shares on September 24, 2026.Fri 05:43
MarketBeat
American personal finance blog
- Apple Inc. stock is traded on Nasdaq, and Jefferies Financial Group restated a hold rating on the company.Mon 17:22
- MarketBeat aggregates data on IDT Corporation stock performance.Mon 17:15

Related events

MarketBeat aggregates company rating data regarding Gorman-Rupp Company, following the issuance of a report by Freedom Capital.Jun 26
Freedom Capital raised its rating on Intrepid Potash to strong-buy.Sep 3
MarketBeat reported on stock ratings and data, following a rating raise by Freedom Capital.Sep 3
MarketBeat provided average ratings and target price for Eagle Financial Services Inc., and Freedom Capital raised shares to strong-buy.Aug 31

Coverage

Newest first; wire copies grouped

Jul 18tickerreport.com